Figures & data
Figure 1. a. Increase in chest CT in Denmark between 2011 and 2021. b. Increase in proportion of stage I-II in Denmark between 2011 and 2021 para. c. Development in proportion of stages IA to IIB among Danish patients diagnosed with lung cancer between 2015 and 2021.
![Figure 1. a. Increase in chest CT in Denmark between 2011 and 2021. b. Increase in proportion of stage I-II in Denmark between 2011 and 2021 para. c. Development in proportion of stages IA to IIB among Danish patients diagnosed with lung cancer between 2015 and 2021.](/cms/asset/5d5193e8-c39d-4bc5-b02c-2667f958a83a/zecr_a_2313311_f0001_oc.jpg)
Figure 2. a. Proportion of stage IA lung cancer in Danish regions 2021. b. Correlation between proportion of stage IA lung cancer and chest CT per 1,000 inhabitants. c. All-cause survival rates of Danish lung cancer patients across all stages from 2016–2021.
![Figure 2. a. Proportion of stage IA lung cancer in Danish regions 2021. b. Correlation between proportion of stage IA lung cancer and chest CT per 1,000 inhabitants. c. All-cause survival rates of Danish lung cancer patients across all stages from 2016–2021.](/cms/asset/5913de87-10b1-4e0f-abc9-772109721166/zecr_a_2313311_f0002_oc.jpg)
Table 1. Audit of stage IV lung cancer: follow-up of nodules.
Table 2. Audit of stage IV lung cancer: missed nodules.
Data availability statement
Data on CT examinations and lung cancer stage distribution are publicly available. Anonymized data from the clinical auditing will be made available at reasonable request and after acceptance of the hospital directors.